Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| InovoBiologic Inc. | INDUSTRY |
| Canadian Center for Functional Medicine | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To determine palatability and extent to which escalating doses of a novel highly viscous polysaccharide [NVP] reduces postprandial glycemia when added to a liquid and a solid meal.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Placebo Comparator | White Bread |
|
| 2 | Placebo Comparator | White Bread and Margarine Control |
|
| 3 | Placebo Comparator | Glucose drink control |
|
| 4 | Experimental | White bread and margarine or Glucose drink |
|
| 5 | Experimental | White bread and margarine or Glucose drink |
|
| 6 | Experimental | White bread and margarine or Glucose drink |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PolyGlycopleX (PGX) | Dietary Supplement | 2.5 grams of PGX |
| |
| Measure | Description | Time Frame |
|---|---|---|
| postprandial glycemia | Acute study measuring postprandial glucose levels over 2 hours |
| Measure | Description | Time Frame |
|---|---|---|
| The glucose reduction index potential (GRIP). The GRIP factor is the reduction in glycemic index units per gram of fiber. | Data analysis |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Alexandra L Jenkins, PhD, RD | Glycemic Index Laboratories, Inc | Study Director |
| Thomas MS Wolever, MD | Glycemic Index Laboratories, Inc | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Glycemic Index Laboratories, Inc. | Toronto | Ontario | M5C 2X3 | Canada |
Not provided
| ID | Term |
|---|---|
| C540519 | PolyGlycoplex |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| PolyGlycopleX (PG) |
| Dietary Supplement |
5.0 grams of PGX |
|
| PolyGlycopleX | Dietary Supplement | 7.5 grams of PGX |
|
| Control | Dietary Supplement | 0g of PGX |
|
| Second Control | Dietary Supplement | 0g of PGX |
|